NAGE
Niagen Bioscience Inc · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +9.1% ·
share flow +28.4% ·
net new positions +8.3%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | -3 | 22.70M | $72.52M | +6 | −9 |
| Q1 2026 | 72 | -9 | 26.61M | $117.87M | +3 | −12 |
| Q4 2025 | 81 | 0 | 27.14M | $172.59M | +1 | −1 |
| Q3 2025 | 17 | +1 | 16.56M | $154.47M | +2 | −1 |
| Q2 2025 | 13 | -2 | 14.28M | $205.83M | n/a | −2 |
| Q1 2025 | 12 | +1 | 6.49M | $44.82M | +1 | n/a |
| Q4 2024 | 11 | +2 | 5.06M | $26.83M | +2 | n/a |
| Q3 2024 | 8 | +1 | 2.02M | $7.36M | +3 | −2 |
| Q2 2024 | 7 | n/a | 2.06M | $5.62M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 1.28M | +26.9% | $8.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.18M | +2.1% | $8.14M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Arrowstreet Capital ✦ | 989.87K | +49.3% | $6.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 927.24K | +1.3% | $6.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 600.90K | +165.8% | $4.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 523.10K | -26.6% | $3.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 352.14K | +1450.5% | $2.43M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 8 | Marshall Wace ✦ | 298.98K | New | $2.06M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | GAMCO Investors ✦ | 142.80K | +1.3% | $985,320 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 106.90K | +301.6% | $737,603 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 51.21K | -10.6% | $354,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 38.39K | -69.8% | $264,912 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $2.06M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 142 holders, 36.40M shares, $156.67M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.